Clinical correlates
REGRESSION, REGRESSION
Finally, to assess whether there was any relationship between these groups of metabolites and clinical outcome following ICU admission, we used linear regression analysis to examine the relationship between the 20 metabolites varying over time and the primary clinical endpoint of change in muscle mass during admission (restricted to only n = 35 for this analyses due to need for complete data sets for all at 0 and 10 days). Patients in this cohort had a mean RFSummary of Linear Regression Analyses of relationship between significantly changing metabolites and change in muscle cross sectional area over 10 day ICU stay. Where two peaks of the same metabolites are seen (representing different isomers) these are numbered separately. “Unknown” refers to metabolites not seen in the HMDB.Summary of Linear Regression Analyses of relationship between significantly changing metabolites and Sequential Organ Failure Assessment (SOFA) score over a 10 day ICU stay. Where two peaks of the same metabolites are seen (representing different isomers) these are numbered separately. “Unknown” refers to metabolites not seein the HMDB.